JNJ

Johnson & Johnson (JNJ) is a publicly traded company listed on NYSE. Johnson & Johnson researches, develops, manufactures, and sells health products, including pharmaceuticals, medical devices, and consumer products worldwide. It operates in the Drug Manufacturers industry within the Healthcare sector.

The current stock price of JNJ is $267.37, with a change of -2.21% in the latest session. Stock prices are updated during market hours and may be delayed.

Yes, JNJ pays dividends with a current dividend yield of 3.02%. Dividend payments are typically made quarterly, though the exact schedule varies. Check the dividend calendar for upcoming ex-dividend dates.

The P/E (Price-to-Earnings) ratio of JNJ is 15.80. This P/E ratio is within a moderate range for many sectors. The P/E ratio compares the stock price to earnings per share and is commonly used for valuation.

JNJ has a market capitalization of $380.00 billion, making it a mega-cap company. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.

JNJ belongs to the Healthcare sector specifically in the Drug Manufacturers industry. Understanding a company's sector helps investors compare it to peers and understand industry-specific trends that may affect performance.

JNJ is scheduled to report earnings on October 13, 2026. Analysts estimate EPS of $3.05. Earnings reports can significantly impact stock prices as they reveal the company's financial performance.